# Zhongshan Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/zhongshan-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 48.5 |
| Citations | 3,392,154 |
| City | Shanghai |
| Country | CN |
| Description | Zhongshan Hospital is a research organisation in Shanghai, CN. OpenAlex records 43,120 works and 3,392,154 citations for it. 13,201 researchers list it as their most recent affiliation. |
| Homepage | https://www.zs-hospital.sh.cn |
| OpenAlex ID | https://openalex.org/I4210127074 |
| Region | Shanghai |
| Researchers | 13,201 |
| ROR ID | https://ror.org/032x22645 |
| Type | healthcare |
| Works | 43,120 |

## University papers

- [Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study](https://scholariq.org/papers/associations-of-fats-and-carbohydrate-intake-with-cardiovascular-disease-and/)
- [Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma](https://scholariq.org/papers/single-cell-landscape-of-the-ecosystem-in-early-relapse-hepatocellular-carcinoma/)
- [Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-hepatocellular-carcinoma-2019/)
- [Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-primary-liver-cancer-2022-edition/)
- [Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma](https://scholariq.org/papers/dissecting-spatial-heterogeneity-and-the-immune-evasion-mechanism-of-ctcs-by/)

## University top topics

Showing 8 of 25.

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.